Differential diagnosis of an intra-axial brain lesion. Tumor, infection, or inflammation?

Zoe Papoutsou, Christina Aslanidi, Sofia Athanasiou

Full Text:

PDF

References


Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, König F. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 Jul 1;131(7):1759-75.

Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ. MRI findings in tumefactive demyelinating lesions: a systematic review and meta-analysis. American Journal of Neuroradiology. 2018 Sep 1;39(9):1643-9.

Nakayama M, Naganawa S, Ouyang M, Jones KA, Kim J, Capizzano AA, Moritani T. A review of clinical and imaging findings in tumefactive demyelination. American Journal of Roentgenology. 2021 Jul 19;217(1):186-97.

Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. American Journal of Roentgenology. 2004 Jan;182(1):195-9.

Balloy G, Pelletier J, Suchet L, Lebrun C, Cohen M, Vermersch P, Zephir H, Duhin E, Gout O, Deschamps R, Le Page E. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. Journal of Neurology. 2018 Oct;265:2251-9.

Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A, Litt AW, Zagzag D. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. American Journal of Neuroradiology. 2001 Jun 1;22(6):1109-16.

Fallah A, Banglawala S, Ebrahim S, Paulseth JE, Jha NK. Tumefactive demyelinating lesions: a diagnostic challenge. Canadian journal of surgery. 2010 Feb;53(1):69.

Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: a comprehensive review. Multiple sclerosis and related disorders. 2017 May 1;14:72-9.




DOI: http://dx.doi.org/10.36162/hjr.v9i1.550

Refbacks

  • There are currently no refbacks.